Core Viewpoint - Aesthetic Medical International Holdings Group Limited (AIH) has received a determination letter from Nasdaq indicating that its securities will be delisted due to failure to meet continued listing conditions, with trading expected to be suspended on May 21, 2024 [1] Group 1: Company Operations - AIH is a leading provider of aesthetic medical services in China, operating treatment centers across major cities, particularly in the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area [3] - The company offers a range of services including surgical and non-surgical aesthetic treatments, as well as general medical services [3] Group 2: Market Transition - Following the delisting from Nasdaq, AIH anticipates that its American Depositary Shares (ADSs) will be quoted on the over-the-counter market operated by OTC Markets Group Inc, although there is no guarantee of continued trading [2] - The company asserts that the delisting will not significantly impact its operations within the aesthetic medical industry in mainland China, emphasizing a commitment to enhancing operational management and driving performance growth [2]
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel